At a glance
ClinicalIndex Comparison RecordN/ACompleted· 40 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Biorepository of Biospecimen Samples in Matched Healthy Control Participants and Participants Diagnosed With Diabetic Kidney Disease, Chronic Kidney Disease, or Type 2 Diabetes
In Brief
An observational study for Diabetic Kidney Disease and 3 related conditions. Completed, enrolled 40 participants across 1 site.
Detailed Summary
The Investigators will generate a repository of human biosamples across therapeutic areas that will be used to identify disease-associated biomarkers and potential targets with immune and multi-omics profiling. This sample collection and analysis from people living with type 2 diabetes, or chronic or diabetic kidney disease will lay the groundwork for an extensive network of biosample access and linked datasets that will provide an invaluable resource for translational research.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsNovo Nordisk A/S
Timeline
N/ACompletedFinished
2023202420252026
First PostedNov 2022
Enrollment StartDec 2022
Primary CompletionAug 2023
TodayJul 2026
First PostedNov 30, 2022
Enrollment StartDec 15, 2022
Primary CompletionAug 23, 2023
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 3.6 years ago